HIGHLIGHTS
- who: Erxi Wu and Xuejing Wang from the Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, Institute of have published the paper: Identification of BAG5 as a Potential Biomarker for Parkinson`s Disease Patients With R492X PINK1 Mutation, in the Journal: (JOURNAL)
- what: The authors first found that the expression levels of BAG5 in the skin tissues from a small cohort of PD patients with R492X PINK1 mutation markedly decreased compared with those from the healthy control subjects. The authors show that BAG5 promotes R492X mutated PINK1 protein degradation in this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.